TY  - JOUR
AU  - Bergami, Maria
AU  - Manfrini, Olivia
AU  - Nava, Stefano
AU  - Caramori, Gaetano
AU  - Yoon, Jinsung
AU  - Badimon, Lina
AU  - Cenko, Edina
AU  - David, Antonio
AU  - Demiri, Ilir
AU  - Dorobantu, Maria
AU  - Fabin, Natalia
AU  - Gheorghe-Fronea, Oana
AU  - Jankovic, Radmilo
AU  - Kedev, Sasko
AU  - Ladjevic, Nebojsa
AU  - Lasica, Ratko
AU  - Loncar, Goran
AU  - Mancuso, Giuseppe
AU  - Mendieta, Guiomar
AU  - Miličić, Davor
AU  - Mjehović, Petra
AU  - Pašalić, Marijan
AU  - Petrović, Milovan
AU  - Poposka, Lidija
AU  - Scarpone, Marialuisa
AU  - Stefanovic, Milena
AU  - van der Schaar, Mihaela
AU  - Vasiljevic, Zorana
AU  - Vavlukis, Marija
AU  - Vega Pittao, Maria Laura
AU  - Vukomanovic, Vladan
AU  - Zdravkovic, Marija
AU  - Bugiardini, Raffaele
PY  - 2023
DO  - 10.1161/JAHA.122.028939
UR  - http://hdl.handle.net/20.500.12105/16397
AB  - Background Empiric antimicrobial therapy with azithromycin is highly used in patients admitted to the hospital with COVID-19, despite prior research suggesting that azithromycin may be associated with increased risk of cardiovascular events. Methods...
LA  - eng
PB  - Wiley
KW  - Cardiovascular Diseases
KW  - COVID-19
KW  - Humans
KW  - Azithromycin
KW  - COVID-19 Drug Treatment
KW  - SARS-CoV-2
TI  - Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID-19 and Preexisting Cardiovascular Disease.
TY  - journal article
ER  -